Lamotrigine Extended Release
Product Images NDC 63629-7020

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine Extended Release (NDC 63629-7020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine Er Tabs 1

Lamotrigine Er Tabs 1
Chemical structure of the active ingredient shown, depicting a triazine ring bonded to a chlorinated phenyl ring with amino groups, consistent with lamotrigine.*
FDA Label Image

Lamotrigine Er Tabs 2

Lamotrigine Er Tabs 2
A cumulative responder rate graph comparing Lamotrigine Extended Release (E R) and placebo. The x-axis shows the percent of patients from 100 to 0, and the y-axis shows the responder rate ranging from worsening (-100%) to improvement (100%). Two lines represent patient responses: a solid line for Lamotrigine E R (N=70) and a dashed line for placebo (N=73). The graph illustrates a higher responder rate for Lamotrigine E R versus placebo.*
FDA Label Image

Lamotrigine Er Tabs 3

Lamotrigine Er Tabs 3
A cumulative responder rate graph showing percent of patients on the horizontal axis (from 0 to 100) and responder rate (equal or greater improvement versus worsening) on the vertical axis (from -100% to 100%). It compares Placebo (dashed line) and Lamotrigine Extended Release (solid line) groups, with sample sizes of 120 and 116, respectively. The graph illustrates the proportion of patients experiencing various levels of improvement or worsening.*
FDA Label Image

Lamotrigine Er Tabs 4

Lamotrigine Er Tabs 4
Lamotrigine Extended-Release Tablets presented as round, colored tablets in various strengths: 25 mg (light yellow), 50 mg (white), 100 mg (red), 200 mg (yellow), 250 mg (light gray), and 300 mg (dark gray). Each tablet is imprinted with strength-specific codes. Labeler is Bryant Ranch Prepack.*
FDA Label Image

Label Image (Lbl636297020)

Label Image (Lbl636297020)
Lamotrigine ER 300mg Tablet packaging label from Bryant Ranch Prepack. It compares to Lamictal XR 300mg Tablet by Zhejiang Huahai Pharma Co Ltd. The label includes storage instructions at 20°-25°C (68°-77°F) and a warning to keep drugs out of children's reach. The package count is 30 tablets with NDC 63629-70201.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.